This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsParkinson's Disease Mechanisms and Treatments · Alzheimer's disease research and treatments · Ginkgo biloba and Cashew Applications
Following the publication of this article and associated Expression of Concern [1,2], additional concerns were raised with results presented in Figs 1–3. Specifically,
The authors did not respond to editorial communications regarding the concerns above or the concerns summarised in [2]. In the absence of an author response and the underlying data, these issues cannot be resolved.
In light of the concerns with this article described above and in [2], which call into question the reliability and integrity of the published results, the PLOS One Editors retract this article.
DCM responded but expressed neither agreement nor disagreement with the editorial decision. VD, JHL, JC, JW, AO, CS, KS, EM, and AS either did not respond directly or could not be reached.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Duka V, Lee J-H, Credle J, Wills J, Oaks A, Smolinsky C, et al. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer’s diseases. P Lo S One. 2013;8(9):e 75025. doi: 10.1371/journal.pone.0075025 24073234 PMC 3779212 · doi ↗ · pubmed ↗
- 2PLOS ONE Editors. Expression of Concern: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases. P Lo S One. 2023;18(12):e 0295638. doi: 10.1371/journal.pone.0295638 38051714 PMC 10697507 · doi ↗ · pubmed ↗
